Laatste update :
19/11/2024
geneesmiddel tegen kanker   Vinblastine sulfate  
injecteerbaar geneesmiddel
Stabiliteit in oplossing Stabiliteit in mengsels Factoren die de stabiliteit beïnvloeden Verenigbaarheden Toedieningswijze Literatuur pdf
   Molecuulstructuur  

Merknamen in verschillende landen   Merknamen in verschillende landen     

Handelsnamen zijn slechts een indicatie; de samenstelling van hulpstoffen kan per land variëren afhankelijk van de fabrikant

Blestinib Mexico
Cytoblastin Egypte, Maleisië
Lemblastine Chili, Colombia, Mexico
Oncoblastin Colombia
Uniblastin Peru
VBlastin Indië
Velbe Australië, Chili, Denemarken, Finland, Frankrijk, Griekenland, Groot Britannië, Italië, Luxemburg, Marokko, Nederland, Noorwegen, Oostenrijk, Saudi-Arabië, Verenigde Arabische Emiraten, Zweden, Zwitserland
Velblastin Egypte, Maleisië
Vinblasine Luxemburg
Vinblastin Hongarije, Polen
Vinblastina Argentinië, Chili, Colombia, Ecuador, Mexico, Peru, Roemenië, Spanje
Vinblastine Australië, België, Canada, Frankrijk, Groot Britannië, Ierland, Iran, Nederland, nieuw Zeeland, Saudi-Arabië, Tunisie, USA
Vinblastinsulfat Duitsland
Vinblatine Maleisië
Vinko Turkije
Literatuur   injecteerbaar geneesmiddel   Literatuur : Vinblastine sulfate  
type publicatie
3 Artikel Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
81 Artikel Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678.
84 Artikel Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
99 Artikel Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
144 Artikel Dine T, Luyckx M, Cazin JC, Goudaliez F, Mallevais ML.
Stability and compatibility studies of vinblastine, vincristine, vindesine and vinorelbine with PVC infusion bags.
Int J Pharm 1991 ; 77: 279-285.
167 Artikel Francomb MM, Ford JL, Lee MG.
Adsorption of vincristine, vinblastine, doxorubicin and mitoxantrone to in-line intravenous filters.
Int J Pharm 1994 ; 103: 87-92.
169 Artikel Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
182 Artikel Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
244 Artikel Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
248 Artikel Trissel LA, Martinez JF.
Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection.
Am J Hosp Pharm 1993 ; 50: 300-304.
249 Artikel Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
251 Artikel Trissel LA, Gilbert DL, Martinez JF.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
307 Artikel Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
334 Artikel Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
335 Artikel Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406.
481 Artikel Beijnen JH, Vendrig DEMM, Underberg WJM.
Stability of vinca alkaloid anticancer drugs in three commonly used infusion fluids.
J Parenter Sci Technol 1989 ; 43: 84-87.
492 Artikel Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189.
763 Artikel Cohen MH, Jonhson-Early A, Hood MA, McKenzie M, Citron ML, Jaffe N, Krasnow SH.
Drug precipitation within IV tubing : A potential hazard of chemotherapy administration.
Cancer Treat Rep 1985 ; 69: 1325-1326.
827 Artikel Black J, Buechter DD, Thurston DE.
Stability of vinblastine sulfate when exposed to light.
Drug Intell Clin Pharm 1988 ; 22: 634-636.
905 Artikel Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
921 Artikel Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
1009 Artikel Black J, Buechter DD, Chinn JW, Gard J, Thurston DE.
Studies on the stability of vinblastine sulfate in aqueous solution.
J Pharm Sci 1988 ; 77: 630-634.
1157 Artikel Vendrig DEMM, Smeets BPGM, Beijnen JH, van der Houwen OAGJ, Holthuis JJM.
Degradation kinetics of vinblastine sulphate in aqueous solutions.
Int J Pharm 1988 ; 43: 131-138.
1229 Artikel Weir PJ, Ireland DS.
Chemical stability of cytarabine and vinblastine injections.
Br J Pharm Pract 1990 ; 12: 53-54, 60.
1410 Artikel Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1423 Artikel Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1625 Artikel Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1727 Artikel Mittner A, Vincze Z, Jemnitz K.
Stability of vinblastine sulphate containing infusions.
Pharmazie 1999 ; 54: 625-626.
1953 Artikel Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
3540 fabrikant Heparin sodium - Summary of Product Characteristics.
Wockhardt 2010
3578 fabrikant Cisplatin - Summary of Product Characteristics
Accord Healthcare 2011
3644 fabrikant Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010

  Mentions Légales